# 🧬 CGT 每日情报 (Daily Brief)
> **日期**: 2026-02-04 | **更新时间**: 09:19 (北京时间)
> **监控范围**: Global (In vivo/FDA) & China (NMPA/Biotech)

---

## 🌍 全球前沿 (FDA / In vivo / MNCs)
- *当前暂无过去 24 小时内的相关重磅全球资讯。*

---

## 🇨🇳 中国动态 (NMPA / Domestic Players)
- `[06:23]` **中国将在拟议机制中放宽创新药的初始定价限制**
  <br><small>🇬🇧 *China to Relax Initial Pricing Restrictions on Innovative Drugs in Proposed Mechanism* [🔗Source](https://news.google.com/rss/articles/CBMixgFBVV95cUxPQ1VCTEN1akc0YmtrTndjVk5xb211bV9YM3AxZF85anY2dHFrZkdyMldJT3hVNXBCRXVSS0Z6eUw3aDczVUZrUjk4cHFzdGRSUTRjdXdUQkZfZ1k4SzVSQndweWlGSWRGTmVxdTFtOWFEQUtMNy10MVJCS3VqRzhMbHR1by1idUdRN1Jvc3lwY3FGamV3VlpPY2UyaUhONW9OLVFKUU01a2I1Ry1XU1Nlb0JtSDhVaEp2QW5KRmJ1bkhpV0FaekE?oc=5)</small>
- `[18:07]` **Anixa Biosciences 获得美国采用名称委员会批准其 CAR-T 疗法的非专有名称，这是未来商业化的关键一步**
  <br><small>🇬🇧 *Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization* [🔗Source](https://news.google.com/rss/articles/CBMipgJBVV95cUxOcXRsdklCUmR6UkpvQXE0dWd5cGhmSVpOTkpmSDd4VUlqYlNwNXlXMlhtOTBka0ExWW5yUGdUVVJxa1BmRUY3a0l1M0ZTYXBISUtHMnJ2WENBazVwR0tQRWVRYVNmTkw0ZWtHTjZEaUF1UHlYUTN5NXpJeVl0Y3E3Yk9CRElkZWtnajcwbGpEbjFOYmhRc3pGUzVJTTJQNF9rMzNCOWJaa3RUVDVDczVrWjNNTXpPUnFjeEwxVkxKUldPcXJVeW5SaFpRQUlzNUJWWUlYMnhHU2NoWUFseWFrX0FQSWdnTWhMVmFrMTRjM3B3Tm4xdWtUdW53SWVNNDlXSnN5eFE0TFRJYy1sdkpuME14dUF5NjFYZnNkSXI1Z3habGItdGc?oc=5)</small>
- `[18:04]` **恒润达生全链条自主创新CAR-T产品恒凯莱（雷尼基奥仑赛注射液）为R/R LBCL患者点亮长生存曙光** [🔗阅读原文](https://news.google.com/rss/articles/CBMif0FVX3lxTFBsbWpjX2JUWUQ1c1N6djlXWHNzSXpiNkZFSWt0c0dqTmxxLXZ2SFVjbm5vT29yM1NKdlhTLUxXbDNkNXNBSy12ZEl0ZjQwbHk1dUtVSXRDWWNNRmxxTURURUdfb1dEejJDdWFfWGt1OFVqV1NpWktvcERzRk9saDg?oc=5)
- `[17:27]` **NAVLIN 监管综述：批准和特殊指定**
  <br><small>🇬🇧 *NAVLIN Regulatory Roundup: Approvals and Special Designations* [🔗Source](https://news.google.com/rss/articles/CBMipAFBVV95cUxNdDZ0TXhSZHUwbVg0TVFUSENIUnEydWdXQ0taanE5TjVyeEg4d2ZXOC01TEN5c21fUEhFRGJ6VHRjamFRNTZoSkNXTkJsZUh4M3NZNTBWMzJDOE5HV3V2clNhbUNmUDR0UFZVd09SYU91RHYySkFnZFhKb3hEWnZLc0F3bmZYdHBZREhGZHlhbkhMWlZNbGtQTW5DZTc2LU1sR0pycA?oc=5)</small>
- `[15:33]` **莱芒生物：代谢增强型CAR-T疗法 实现细胞治疗颠覆性突破** [🔗阅读原文](https://news.google.com/rss/articles/CBMiV0FVX3lxTE9NeGVuN3FnQnFId3lHVUFiaEk1RGxoTUFHaFA3c1Vsb0hQZFpud0tEN3RDa1VJSUlZNXhwWDRMcXJQek9scGVNS1BFSW5hcFAySGpRa0NLcw?oc=5)
- `[11:21]` **STTT：华西医院王永生/李丹团队开发新型CAR-T细胞疗法，临床效果优异** [🔗阅读原文](https://news.google.com/rss/articles/CBMiXkFVX3lxTE1mc0xvM0wwNldjcTJHdDdWdnB1WXFMRmpnZ1ExQ2lYMXExaGFldW51am1DQ1k1Y0hxZnpWQjU5RGNfNXIyR3lGZmpGcmJvQWpuQU44YmFpckNiYXA2V2c?oc=5)
- `[10:39]` **🔥In-vivo | 2025年In Vivo CAR-T竞争格局及BD情况：MNC重金布局，中国药企多点开花迎突破！** [🔗阅读原文](https://news.google.com/rss/articles/CBMiWkFVX3lxTE9sX2EtTmlONlZQejdOVndzS3lHWEMtanhFZjZTSEdKLWpBX0YxYVZHSm54RnpfUDlBQ1dFQmh5WnkzTDJiSjBRa2R3RUU0NkFCb211enVzNVIzUQ?oc=5)
